MPLT
Financials
- Market Capitalization 1.68 B
- Employee 133
- Founded 2018
- CEO N/A
- Website www.maplightrx.com
- Headquarter Delaware, United States
- FIGI BBG01JZ5DBQ0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2120 |  FTRE Fortrea Holdings Inc. - Common Stock | 18.05 USD | +1.06% | +5.68% | +8.02% | +254.62% | 1.71 B USD | ||
| 2123 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.47 USD | +1.73% | +12.13% | +28.88% | +143.23% | 1.67 B USD | ||
| 2132 |  IMCR Immunocore Holdings plc - American Depositary Shares | 33.73 USD | +3.82% | +4.85% | +16.47% | +0.75% | 1.72 B USD | ||
| 2142 |  ABSI Absci Corporation - Common Stock | 10.36 USD | +1.47% | -9.12% | +40.76% | +289.47% | 1.62 B USD |
Frequently asked questions about MapLight Therapeutics, Inc. - Common Stock
What is the MapLight Therapeutics, Inc. - Common Stock stock price today?
The current price of MapLight Therapeutics, Inc. - Common Stock (MPLT) is 37.11. Over the past 24 hours, the stock has changed by +1.48%. Follow the MPLT chart for real-time price dynamics.
What is the stock ticker of MapLight Therapeutics, Inc. - Common Stock?
MapLight Therapeutics, Inc. - Common Stock trades under the ticker MPLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MapLight Therapeutics, Inc. - Common Stock stock going up?
MPLT has changed by +2.18% over the last week, +33.06% over the last month, and +95.32% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was MapLight Therapeutics, Inc. - Common Stock net income for the last quarter?
MapLight Therapeutics, Inc. - Common Stock reported net income of -60.67 M for the last quarter. The previous quarter showed -79.55 M, which means net income changed by +23.73%.
How many employees does MapLight Therapeutics, Inc. - Common Stock have?
As of the latest available data, MapLight Therapeutics, Inc. - Common Stock has 133 employees. Workforce size can provide additional context about the company's scale and operations.
What is MapLight Therapeutics, Inc. - Common Stock EBITDA?
MapLight Therapeutics, Inc. - Common Stock EBITDA is -65.16 M, and its EBITDA margin is 1.63 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MapLight Therapeutics, Inc. - Common Stock stock?
You can buy MapLight Therapeutics, Inc. - Common Stock (MPLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MapLight Therapeutics, Inc. - Common Stock stock?
Investing in MapLight Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MPLT chart and related analysis on metatrader.com as part of your research.